Collective Concentrates Safety Sativa 
Cannabis Law Report
SEPTEMBER 15, 2021
Delta-8 tetrahydrocannabinol, also known as delta-8 THC, is a psychoactive substance found in the Cannabis sativa plant, of which marijuana and hemp are two varieties. As a result, concentrated amounts of delta-8 THC are typically manufactured from hemp-derived cannabidiol (CBD). . synthetic conversion).
The Joint Blog
JULY 1, 2019
However, although both plants belong to the Cannabis Sativa family, they are two different subspecies with different properties. The Cannabis Sativa L. These buds contain cannabinoids in high concentrations compared to other parts of the plant including the leaves, stalk, and roots. In fact, the first U.S. The hemp bud- flower.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
NOVEMBER 2, 2021
We wanted to investigate, so after collecting samples from online stores and brick-and-mortar smoke shops, we commissioned FESA Labs to perform independent testing on 51 delta-8 products. Testing for Safety: Are Impurities a Problem? Concentrates. But it can’t really be as bad as it sounds, can it? Table of Contents.
Project CBD
AUGUST 23, 2023
Current Market Dynamics Loopholes in the 2018 Farm Bill The 2018 Farm Bill defines “hemp” as “the plant Cannabis sativa L. 8 Safety Issues Associated with Synthetic Cannabinoids This new generation of designer drugs is reminiscent of “Spice,” “K2,” and other synthetic cannabinoids that emerged in the illicit drug market in the early 2000s.
Kind Meds (Cannabis Education Blog)
FEBRUARY 20, 2023
This is true whether you prefer to smoke cured flower, vape cannabis concentrates , use medicinal cannabis topicals, or consume cannabis edibles. Consistent techniques when it comes to growing, collection, handling, and more are necessary for quality products. Strains include a host of user favorites across sativa, indica, and hybrids.
Cannabis Law Report
NOVEMBER 24, 2021
However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Data collection. Framings that more often carried a negative tone were related to poor evidence and safety issues.
Cannabis Law Report
DECEMBER 8, 2019
AJEM’s mission is to create, collect, and disseminate credible cannabis research data. Indeed, the discovery of the endocannabinoid system (ECS), and the fact that it can be modulated by exogenous phytocompounds called cannabinoids produced by the Cannabis sativa L. plant (cannabis), has sparked a revolution in health care.
Expert insights. Personalized for you.
105 
Let's personalize your content